TABLE 2.
Participants demographic information
| Study ID | Gender | Age | AED(s) | MRI Findings | Seizure Type |
|---|---|---|---|---|---|
| 01 | F | 75 | AC, LZ | Normal | A |
| 02 | F | 50 | CB | Left polymicrogyria | CP, N |
| 03 | F | 56 | LC, LV | Right mesial temporal sclerosis | CP, GTC |
| 04 | M | 29 | BR, LC, LM, OX | Normal | N |
| 05 | F | 26 | CB, LM, LC, CL | Normal | SP, CP, N |
| 06 | M | 32 | LV, CB, VA, CL | Generalized brain atrophy | CP, GTC |
| 07 | M | 33 | LM | Right temporal encephalocele | CP |
| 08 | M | 28 | PH, LC, LZ | Occipital horn dilatation | CP, GTC |
| 09 | F | 42 | LM, LC | Normal | CP |
| 10 | F | 53 | CB, LV | Normal | CP, GTC |
| 11 | M | 67 | CB, LC, PR | Normal | CP |
| 12 | F | 42 | TO | Multiple bilateral white matter hyperintensities | CP |
| 13 | F | 63 | VA | Normal | CP |
Abbreviations: A, absence; AC, acetazolamide; BR, brivaracetam; CB, carbamazepine; CL, clobazam; CP, complex partial; GTC, generalized tonic‐clonic; LC, lacosamide; LM, lamotrigine; LV, levetiracetam; LZ, lorazepam; N, nocturnal; OX, oxcarbazepine; PH, phenytoin; PR, perampanel; SP, simple partial; TO, topiramate; VA, valproic acid.